Exion™’s breakthrough fractional radiofrequency microneedling with artificial intelligence technology is redefining the aesthetics industry.
Designed with meticulous attention to detail, ™ is the result of 6 years of extensive research and development from the innovators at BTL Aesthetics. Exion™ is a multi-platform device featuring multiple applicators designed for highly sought-after treatments on the face and body, including RF microneedling and the ability to achieve deep energy penetration and non-invasive hyaluronic acid production with minimal discomfort or downtime. It represents a breakthrough in aesthetics solutions, providing a comprehensive set of tools and functionalities to address the key challenges faced by aesthetic healthcare professionals and the evolving needs of the market.
At the heart of Exion™ lies its revolutionary patented technology which sets it apart from anything else in the industry. It uses breakthrough fractional radiofrequency microneedling with Artificial Intelligence (AI) technology for precise energy delivery and deeper tissue penetration up to 7.5mm without full needle insertion and with less discomfort.
AI technology ensures optimal energy delivery and allows for a single pass procedure. As a result, patients can achieve significant improvements in the skin while minimising the usual discomfort of deep tissue treatments. It is also the first combined technology (using monopolar RF and targeted ultrasound) to boost natural production of hyaluronic acid without injectables.
‘We are thrilled to introduce Exion™ to the market,’ says Gareth Pepper, Sales Director, BTL Aesthetics Australia. ‘Exion™ represents another significant milestone in our mission to transform the aesthetics landscape. By harnessing the power of AI, it allows for deeper tissue penetration to deliver consistent and reproducible results with minimal downtime and less pain.
‘With the additionsl patented blend of monopolar RF and targeted ultrasound, this is the first technology to boost HA naturally in the skin by 224%1, without the requirement of injectables. This unparalleled innovation and versatility will empower businesses to thrive in an ever-changing world and create a positive impact on our customers’ success.’
Finding from clinical studies concluded that participants who completed the recommended treatment course of four sessions experienced, on average:
- 224% increased in hyaluronic acid1
- 93% improvement in acne scars and wrinkles2
- Improvement in skin texture by 41% and 23% skin hydration3
- 82% of patients found the treatments comfortable4
Exion™ offers a versatile face and body solution designed to treat both the skin and localised adipose tissue. The platform allows for seamless integration with existing workflow to achieve remarkable results with ease.
With advanced functionality, unparalleled performance and a user-centric approach, Exion™ offers an intuitive AI technology to eliminate the guesswork and minimise the learning curve by delivering treatments with unmatched speed and precision, setting a new benchmark for excellence.
Q&A with Dr Sam Patel (US)
Why did you invest in this new technology?
I believe Exion™ is the most cutting-edge and advanced platform on the market for addressing skin on both the face and the body. The fractional RF microneedling handpiece on the Exion™ is currently the most advanced technology in its category. Offering optimal results, patient comfort and quick treatments, Exion™ is a device that just about every practice will inevitably within their practices.
What differentiates Exion™ from other devices on the market?
There are many fractional RF microneedling devices on the market from several great companies. However, the Exion™ device truly shines for three distinct reasons. One, Exion™ is powered by Advanced Artificial Intelligence. Exion™’s AI retrieves impendence from each individual needle, while effortlessly controlling RF pulse duration, RF power and energy delivery in every pulse, allowing treatments to be conducted with only one pass! These two of the third reason: exceptional patient experience. With Exion™ AI technology, single pass treatment, and unique 3.5mm needle penetration depth with an additional 4mm thermal gradient below the needle, this device truly is at the top of its class in the aesthetic market.
What results can you expect from Exion™?
Exion™ is clinically proven to provide an average of 41% improvement in skin texture3, 47% improvement in collagen5, 50% increase in elastin6, 224% increase in hyaluronic acid1, 85% improvement in skin laxity7, and 22% fat reduction in hard-to-reach areas8.
How does this device complement your practice and other modalities you have?
With each practice I have developed, I ensure that each business has four distinct pillars. Each of these resembles a category of aesthetics needed for a business to fully succeed. These four pillars include face, body, skin and wellness. Each practice should contain devices, treatments and services to address each of these categories. What excites me most about Exion™ is that it exclusively addresses each of these categories: The fractional RF microneedling handpiece targets skin, both on the face and body; the RF and targeted ultrasound handpiece for the face further tackles facial skin by boosting the natural production of hyaluronic acid; and the RF and targeted ultrasound handpiece for the body improves skin laxity on the body and destroys localised fat deposits.
How quickly cam you see financial benefits of Exion™?
distinct features of owning any BTL device is that it actually saves your practice money. Specially, with Exion™ fractional RF microneedling, the single pass technology and the benefit of often not requiring numbing allows our practices to run more efficiently while at the same time decreasing the time patients are in the room. This directly translates to seeing more patients per day.
Do you recommend a combination of Emface® and Exion™?
Combination therapy with BTL devices is what make the company so unique. They design each to be able to provide outstanding results on their own, however when combined, the outcomes are truly on another level. Stacking treatments allows patients to have a comprehensive approach to addressing their facial concerns. Emface® allows us to reduce fine lines and wrinkles while also lifting and adding volume back to the face. Exion™ further enhances the appearance of the face by naturally boosting hyaluronic acid production, increasing facial volume and improving skin texture.
How easy is it to ‘sell’ and market these treatments?
With treatments being quick, effective, painless and proven, selling treatments is the easiest part of owning an Exion™ device. In today’s world, patients aren’t only looking for results; they are looking for a positive experience. With Exion™ having both, patients do not need much convincing.
References:
1.Duncan, D, Bernardy, J, Hodkovicova, N & Masek, J. 2022. Increased levels of hyaluronic acid in skin after monopolar radiofrequency and tus treatment: porcine animal study. Presented at the American Society for Laser Medicine and Surgery (ASLMS). San Diego, California.
2.Duncan, D. 2023. Evaluating the efficacy of fractional radiofrequency treatment for facial acne scars and wrinkles: preliminary data. Presented at the American Society for Laser Medicine and Surgery (ASLMS), Phoenix, Arizona.
3.Chilukuri, S & Boyd, C 2022. The simultaneous application of monopolar radiofrequency and targeted ultrasound for improvement of skin hydration and skin texture. Presented at the annual meeting of the Vegas Cosmetic Surgery.
4.Clark-Loeser, LR & Halaas, Y 2022. Efficacy and safety of novel ai-controlled fractional radiofrequency for acne scars treatment and skin texture improvement. Presented at the Annual Meeting of the American Society for Laser Medicine and Surgery.
5.Kent, D, Muller, G 2023. A novel technology combining radiofrequency and targeted ultrasound for improvement in skin laxity: the efficacy and safety evaluation. presented at the American society for laser medicine and surgery (ASLMS), phoenix, arizona, april 13-16, 2023.
6. Kent, D. 2023. Monopolar radiofrequency and targeted ultrasound induces remodeling of fibrillar collagen and elastin fibers: histological porcine model study. Presented at the American society for laser medicine and surgery (ASLMS). San Diego, California, 27th April 2022.
7.Kent, D, Muller, G 2023. A novel technology combining radiofrequency and targeted ultrasound for improvement in skin laxity: the efficacy and safety evaluation. presented at the American society for laser medicine and surgery (ASLMS), phoenix, arizona, april 13-16, 2023. 8.Hayre, N 2023. the efficacy and safety evaluation of a technology using radiofrequency heating with superficial active cooling for localized fat reduction. Cosmetic Dermatology Center, McLean, VA, USA.
